RPL23AP87

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, RPL23AP87 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPL23AP87’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RPL23AP87 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL23AP87 is over-expressed in tumor.

LIHC are the cancer types where RPL23AP87 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL23AP87 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
LIHCAllAll+0.063.0252view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

RPL23AP87–LIHC

Tumor-vs-normal expression box plot for RPL23AP87 RNA in LIHC.

Open the LIHC breakdown →

Exploration